“In Silico Design, Molecular Docking, Molecular Dynamics Simulation, and ADMET Evaluation of Novel Quinazoline Derivatives as EGFR Inhibitors for Non-Small-Cell Lung Cancer”, AMAR, vol. 4, no. 6, pp. 26–71, Jun. 2026, doi: 10.5281/zenodo.21820790.